DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 51248-35-2, H-dl-leu-nca, L-leucine nca, 4-(2-methylpropyl)-1,3-oxazolidine-2,5-dione, Isobutyloxazolidine-2,5-dione, (r,s)-4-isobutyloxazolidine-2,5-dione

Molecular Formula

C₇H₁₁NO₃

Molecular Weight

157.17 g/mol

InChI Key

JHWZWIVZROVFEM-UHFFFAOYSA-N

1 2D Structure

L-Leu-NCA

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-(2-methylpropyl)-1,3-oxazolidine-2,5-dione

2.1.2 InChI

InChI=1S/C7H11NO3/c1-4(2)3-5-6(9)11-7(10)8-5/h4-5H,3H2,1-2H3,(H,8,10)

2.1.3 InChI Key

JHWZWIVZROVFEM-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C)CC1C(=O)OC(=O)N1

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 51248-35-2

2. H-dl-leu-nca

3. L-leucine Nca

4. 4-(2-methylpropyl)-1,3-oxazolidine-2,5-dione

5. Isobutyloxazolidine-2,5-dione

6. (r,s)-4-isobutyloxazolidine-2,5-dione

7. Mfcd02684167

8. 26334-33-8

9. 51018-87-2

10. N-carboxyanhydride L-leucine; N-carboxyleucine Anhydride; Nsc 351903

11. Leucine Anhydride

12. Dl-leucine Nca

13. Mfcd03411292

14. Einecs 257-083-3

15. L-leucine N-carboxyanhydride

16. 3,3,3-triphenylpropionicacid

17. Schembl8647155

18. Dtxsid60871738

19. Act14057

20. Bca24835

21. Einecs 221-692-2

22. Dl-4-isobutyloxazolidine-2,5-dione

23. Mfcd03411293

24. Nsc351903

25. 2, 4-(2-methylpropyl)-, (s)-

26. Akos006228712

27. Nsc 351903

28. Nsc-351903

29. Sb44325

30. Ds-17234

31. Sy007693

32. Sy037764

33. Sy225253

34. Db-020426

35. Cs-0317706

36. Ft-0605180

37. Ft-0690463

38. Ft-0762388

39. J-650064

2.3 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₇H₁₁NO₃
Molecular Weight	157.17 g/mol
XLogP3	1.3
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	2
Exact Mass	157.07389321 g/mol
Monoisotopic Mass	157.07389321 g/mol
Topological Polar Surface Area	55.4 Å²
Heavy Atom Count	11
Formal Charge	0
Complexity	188
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

ABOUT THIS PAGE

Find L-Leu-NCA manufacturers, exporters & distributors on PharmaCompass

L-Leu-NCA

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?